Literature DB >> 28509067

Intracranial calcification in a uremic infant with Wilms' tumor in a solitary kidney.

Hiro Matsukura1, Keijiro Ibuki2, Keiko Nomura2, Hiroyuki Higashiyama3, Asami Takasaki2, Toshio Miyawaki2, Atsushi Aikawa4, Hirokazu Kanegane2.   

Abstract

Wilms' tumor (WT), also called nephroblastoma, is an embryonic neoplasm of the developing kidney. A previously healthy Japanese female infant had WT in a single kidney without associated congenital malformations. Preoperative chemotherapy was started for the preservation of renal tissue and function. Tumor lysis syndrome, disseminated intravascular coagulopathy, and acute renal failure were accompanying. The infant needed surgical intervention and permanent replacement therapy. At the start of emergency hemodialysis, the infant had posterior reversible leukoencephalopathy syndrome because of severe hypertension. During ongoing peritoneal dialysis, the infant suffered from anemia, dietary and fluid restriction, and restriction of time and mobility. Despite alfacalcidol and calcium supplementation, the infant had secondary hyperparathyroidism and remarkably short stature. After waiting for the completion of chemotherapy, renal transplantation from the mother was completed. Successful kidney transplantation promptly corrected preexisting metabolic abnormalities causing secondary hyperparathyroidism. Subsequently, the infant often complained of headache. Computed tomographic scanning revealed calcification in the cerebellum. Refractory secondary hyperparathyroidism was inferred as the cause. A well-functioning graft provided the infant with a greater sense of well-being and enabled her to enjoy a lifestyle free of dialysis, although the infant must continue taking transplant medications and has retained unresolved issues of short stature and ectopic intracranial calcification.

Entities:  

Keywords:  Calcification; Renal transplantation; Secondary hyperparathyroidism; Short stature; Wilms’ tumor

Year:  2012        PMID: 28509067      PMCID: PMC5413644          DOI: 10.1007/s13730-012-0019-0

Source DB:  PubMed          Journal:  CEN Case Rep        ISSN: 2192-4449


  17 in total

1.  Soft tissue calcification in pediatric patients with end-stage renal disease.

Authors:  D S Milliner; A R Zinsmeister; E Lieberman; B Landing
Journal:  Kidney Int       Date:  1990-11       Impact factor: 10.612

2.  K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease.

Authors: 
Journal:  Am J Kidney Dis       Date:  2003-10       Impact factor: 8.860

3.  Treatments and outcomes for end-stage renal disease following Wilms tumor.

Authors:  Yevgeny Grigoriev; Jane Lange; Susan M Peterson; Janice R Takashima; Michael L Ritchey; Dicken Ko; James H Feusner; Robert C Shamberger; Daniel M Green; Norman E Breslow
Journal:  Pediatr Nephrol       Date:  2012-03-20       Impact factor: 3.714

4.  Pediatric hemodialysis: a decade's (1974-1984) perspective.

Authors:  H Trachtman; P Hackney; A Tejani
Journal:  Kidney Int Suppl       Date:  1986-07       Impact factor: 10.545

5.  Intracranial calcifications in childhood. Frequency of occurrence and significance.

Authors:  W L Schey
Journal:  Am J Roentgenol Radium Ther Nucl Med       Date:  1974-11

6.  Cerebellar calcification on computerized tomography.

Authors:  W C Koller; H L Klawans
Journal:  Ann Neurol       Date:  1980-02       Impact factor: 10.422

Review 7.  Intracranial calcifications on CT.

Authors:  Yılmaz Kıroğlu; Cem Callı; Nevzat Karabulut; Cağatay Oncel
Journal:  Diagn Interv Radiol       Date:  2009-12-18       Impact factor: 2.630

Review 8.  Vitamin D deficiency and toxicity in chronic kidney disease: in search of the therapeutic window.

Authors:  Uwe Querfeld; Robert H Mak
Journal:  Pediatr Nephrol       Date:  2010-06-22       Impact factor: 3.714

9.  Intracranial calcification in paediatric computed tomography.

Authors:  B Kendall; N Cavanagh
Journal:  Neuroradiology       Date:  1986       Impact factor: 2.804

Review 10.  Cancer risk following growth hormone use in childhood: implications for current practice.

Authors:  Amanda L Ogilvy-Stuart; Helena Gleeson
Journal:  Drug Saf       Date:  2004       Impact factor: 5.228

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.